J&J | JNJ - PE Price to Earnings


J&J reported 29.43 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Abbott 23.85 1.08 Jun/2026
Amgen 19.84 5.47 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
Baxter International 86 68.9 Dec/2025
Bayer 3.4 8.75 Mar/2026
Becton, Dickinson and Co. 17.68 114.67 Dec/2025
Biogen 13.7 0.32 Mar/2026
Boston Scientific 32.35 5.17 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
CONMED 9.39 17.48 Mar/2026
Cooper Companies 23.27 16.99 Mar/2026
Dexcom 24.73 7.45 Mar/2026
Edwards Lifesciences 26.86 4.76 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Globus Medical 35.3 10.24 Mar/2026
Insulet 38.83 16.24 Mar/2026
Integra LifeSciences 5.07 1.52 Mar/2026
Intuitive Surgical 44.59 11.23 Jun/2026
J&J 29.43 4.9 Jun/2026
Medtronic 19.66 3.1 Mar/2026
Merck 16.52 2.6 Mar/2026
Merit Medical Systems 45.2 6.08 Dec/2025
Novartis 20.17 2.32 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.84 0.14 Mar/2026
Stryker 30.44 1.69 Mar/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teva Pharmaceutical Industries 10.07 0.04 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Zimmer Biomet Holdings 25.47 7.56 Mar/2026
Zoetis 18.8 1.62 Mar/2026